Jaeil Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jaeil Han has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Joshua T. Mendell
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
4 shared publications - Ambro van Hoof
Department of Molecular Genetics and Center for RNA Biology, The Ohio State University, Columbus, USA
2 shared publications - Minseon Kim
Department of Neurology, University of Texas McGovern Medical School, Houston, TX, United States
2 shared publications - Seung-Kyoon Kim
Chungnam National University
2 shared publications Alexandra N. Marshall
Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston and University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030
1 shared publication- Benjamin T. Jones
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by MDPI AG in Non-Coding RNA
- Vol. 12 (5) , 36
A Transcriptome-Wide Analysis Nominates DIO3OS and C9orf139 as Survival-Associated Long Non-Coding RNAs in Glioblastoma
Background: Long non-coding RNAs (lncRNAs) are widely proposed as determinants of temozolomide response in glioblastoma (GBM), but many nominations rest on analyst-derived survival endpoints, screens unadjusted for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and models evaluated with the same data used to select them. We asked which lncRNA–outcome associations remain when endpoint definition, confounder adjustment, and external validation are addressed explicitly. Methods: We analyzed 94 IDH-wildtype, temozolomide-treated primary GBM patients from The Cancer Genome Atlas (TCGA), using the rule-based progression-free interval (PFI) of the TCGA Pan-Cancer Clinical Data Resource and overall survival (OS) as separate endpoints. A joint transcriptome-wide discovery for OS was performed across TCGA and the identically processed CPTAC-3 cohort (n = 282, 209 deaths), the latter unselected for IDH status because IDH annotation is unavailable for CPTAC-3, with adjustment for MGMT promoter methylation status, cellular composition, and expression subtype. Nominated transcripts were tested for external validation in two independent CGGA cohorts, and incremental discrimination was assessed as the optimism-corrected change in C-index (ΔC-index), benchmarked against the gain expected from a transcriptome-wide search alone. Results: No lncRNA was associated with PFI at a transcriptome-wide false-discovery rate (FDR) below 0.05. The joint OS discovery nominated DIO3OS, the only transcript reaching transcriptome-wide significance (hazard ratio 1.38 per standard deviation, 95% confidence interval 1.20–1.58, FDR 0.022), and C9orf139 (FDR 0.065); both were independently significant in each discovery cohort and robust to adjustment for MGMT status, cellular composition, and expression subtype. Both, however, were null with reversed point estimates in the two CGGA cohorts, were unassociated with PFI, and added only modest optimism-corrected discrimination (ΔC-index 0.07–0.11), close to what a transcriptome-wide search alone generates. Replication was thus confined to two cohorts sharing a processing pipeline. Conclusions: We nominate DIO3OS and C9orf139 as candidate survival-associated lncRNAs in GBM, requiring prospective evaluation in cohorts with complete IDH annotation and progression endpoints, and show how endpoint definition, selection optimism, and external validation determine which lncRNA associations survive scrutiny.
- 7 September 2026
- Published by MDPI AG in Non-Coding RNA
- Vol. 12 (5) , 36
Open AccessA Transcriptome-Wide Analysis Nominates DIO3OS and C9orf139 as Survival-Associated Long Non-Coding RNAs in Glioblastoma
Background: Long non-coding RNAs (lncRNAs) are widely proposed as determinants of temozolomide response in glioblastoma (GBM), but many nominations rest on analyst-derived survival endpoints, screens unadjusted for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and models evaluated with the same data used to select them. We asked which lncRNA–outcome associations remain when endpoint definition, confounder adjustment, and external validation are addressed explicitly. Methods: We analyzed 94 IDH-wildtype, temozolomide-treated primary GBM patients from The Cancer Genome Atlas (TCGA), using the rule-based progression-free interval (PFI) of the TCGA Pan-Cancer Clinical Data Resource and overall survival (OS) as separate endpoints. A joint transcriptome-wide discovery for OS was performed across TCGA and the identically processed CPTAC-3 cohort (n = 282, 209 deaths), the latter unselected for IDH status because IDH annotation is unavailable for CPTAC-3, with adjustment for MGMT promoter methylation status, cellular composition, and expression subtype. Nominated transcripts were tested for external validation in two independent CGGA cohorts, and incremental discrimination was assessed as the optimism-corrected change in C-index (ΔC-index), benchmarked against the gain expected from a transcriptome-wide search alone. Results: No lncRNA was associated with PFI at a transcriptome-wide false-discovery rate (FDR) below 0.05. The joint OS discovery nominated DIO3OS, the only transcript reaching transcriptome-wide significance (hazard ratio 1.38 per standard deviation, 95% confidence interval 1.20–1.58, FDR 0.022), and C9orf139 (FDR 0.065); both were independently significant in each discovery cohort and robust to adjustment for MGMT status, cellular composition, and expression subtype. Both, however, were null with reversed point estimates in the two CGGA cohorts, were unassociated with PFI, and added only modest optimism-corrected discrimination (ΔC-index 0.07–0.11), close to what a transcriptome-wide search alone generates. Replication was thus confined to two cohorts sharing a processing pipeline. Conclusions: We nominate DIO3OS and C9orf139 as candidate survival-associated lncRNAs in GBM, requiring prospective evaluation in cohorts with complete IDH annotation and progression endpoints, and show how endpoint definition, selection optimism, and external validation determine which lncRNA associations survive scrutiny.
- 2 August 2026
- Published by Springer Nature
- p. 29-46
RNA Labeling for Measuring RNA Endonucleolytic Cleavage
- 2 August 2026
- Published by Springer Nature
- p. 29-46
RNA Labeling for Measuring RNA Endonucleolytic Cleavage
- 2 August 2026
- Published by Springer Nature
- p. 47-60
Molecular Analysis of miRNA Stability and Decay Dynamics by Northern Blot
- 2 August 2026
- Published by Springer Nature
- p. 47-60
Molecular Analysis of miRNA Stability and Decay Dynamics by Northern Blot
- Open Access
RNA Degradation in Pluripotent Stem Cells: Mechanisms, Crosstalk, and Fate Regulation
Pluripotent stem cells (PSCs) exhibit remarkable self-renewal capacity and differentiation potential, necessitating tight regulation of gene expression at both transcriptional and post-transcriptional levels. Among post-transcriptional mechanisms, RNA turnover and degradation together play pivotal roles in maintaining transcriptome homeostasis and controlling RNA stability. RNA degradation plays a pivotal role in determining transcript stability for both messenger RNAs (mRNAs) and non-coding RNAs (ncRNAs), thereby influencing cell identity and fate transitions. The core RNA decay machinery, which includes exonucleases, decapping complexes, RNA helicases, and the RNA exosome, ensures timely and selective decay of transcripts. In addition, RNA modifications such as 5′ capping and N6-methyladenosine (m6A) further modulate RNA stability, contributing to the fine-tuning of gene regulatory networks essential for maintaining PSC states. Recent single-cell and multi-omics studies have revealed that RNA degradation exhibits heterogeneous and dynamic kinetics during cell fate transitions, highlighting its role in preserving transcriptome homeostasis. Conversely, disruption of RNA decay pathways has been implicated in developmental defects and disease, underscoring their potential as therapeutic targets. Collectively, RNA degradation emerges as a central regulator of PSC biology, integrating the decay of both mRNAs and ncRNAs to orchestrate pluripotency maintenance, lineage commitment, and disease susceptibility.
Open AccessRNA Degradation in Pluripotent Stem Cells: Mechanisms, Crosstalk, and Fate Regulation
Pluripotent stem cells (PSCs) exhibit remarkable self-renewal capacity and differentiation potential, necessitating tight regulation of gene expression at both transcriptional and post-transcriptional levels. Among post-transcriptional mechanisms, RNA turnover and degradation together play pivotal roles in maintaining transcriptome homeostasis and controlling RNA stability. RNA degradation plays a pivotal role in determining transcript stability for both messenger RNAs (mRNAs) and non-coding RNAs (ncRNAs), thereby influencing cell identity and fate transitions. The core RNA decay machinery, which includes exonucleases, decapping complexes, RNA helicases, and the RNA exosome, ensures timely and selective decay of transcripts. In addition, RNA modifications such as 5′ capping and N6-methyladenosine (m6A) further modulate RNA stability, contributing to the fine-tuning of gene regulatory networks essential for maintaining PSC states. Recent single-cell and multi-omics studies have revealed that RNA degradation exhibits heterogeneous and dynamic kinetics during cell fate transitions, highlighting its role in preserving transcriptome homeostasis. Conversely, disruption of RNA decay pathways has been implicated in developmental defects and disease, underscoring their potential as therapeutic targets. Collectively, RNA degradation emerges as a central regulator of PSC biology, integrating the decay of both mRNAs and ncRNAs to orchestrate pluripotency maintenance, lineage commitment, and disease susceptibility.
- 7 July 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (1) , 26-39
MicroRNA turnover: a tale of tailing, trimming, and targets
- 7 July 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (1) , 26-39
MicroRNA turnover: a tale of tailing, trimming, and targets
- 18 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6523) , 1432-+
A ubiquitin ligase mediates target-directed microRNA decay independently of tailing and trimming
Turning the tables on microRNA decay: MicroRNAs help to regulate many genes in animal cells. Each microRNA associates with an Argonaute (AGO) protein, forming a complex in which the microRNA pairs with a messenger RNA (mRNA) target and AGO recruits factors that accelerate mRNA decay. However, for some unusual targets, the reverse occurs: Pairing to the target recruits factors that accelerate microRNA decay rather than degradation of the mRNA. Working independently, Shi et al. and Han et al. elucidate the mechanism of this phenomenon. They found that pairing to the unusual targets recruits a ubiquitin ligase that causes degradation of AGO, thereby exposing the microRNA to cellular nucleases. Mutating the ubiquitin ligase in diverse animals and cell types deregulates numerous microRNAs, implying that this phenomenon is widely deployed to sculpt microRNA levels. Science , this issue p. eabc9359 , p. eabc9546
- 18 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 370 (6523) , 1432-+
A ubiquitin ligase mediates target-directed microRNA decay independently of tailing and trimming
Turning the tables on microRNA decay: MicroRNAs help to regulate many genes in animal cells. Each microRNA associates with an Argonaute (AGO) protein, forming a complex in which the microRNA pairs with a messenger RNA (mRNA) target and AGO recruits factors that accelerate mRNA decay. However, for some unusual targets, the reverse occurs: Pairing to the target recruits factors that accelerate microRNA decay rather than degradation of the mRNA. Working independently, Shi et al. and Han et al. elucidate the mechanism of this phenomenon. They found that pairing to the unusual targets recruits a ubiquitin ligase that causes degradation of AGO, thereby exposing the microRNA to cellular nucleases. Mutating the ubiquitin ligase in diverse animals and cell types deregulates numerous microRNAs, implying that this phenomenon is widely deployed to sculpt microRNA levels. Science , this issue p. eabc9359 , p. eabc9546
- Open Access
- 20 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18521-18529
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
Significance: Feedback control of cholesterol metabolism is essential for cell viability and prevention of heart attacks. Cells acquire cholesterol from receptor-mediated uptake of low-density lipoprotein, which delivers cholesterol to lysosomes. To exert feedback control, cholesterol must reach the endoplasmic reticulum (ER). Here we use a CRISPR screen to show that lysosome-derived cholesterol moves first to the plasma membrane and then to the ER. The last movement requires an enzyme that produces phosphatidylserine. This demonstrates that transmembrane movement of one lipid (cholesterol) requires another lipid (phosphatidylserine). Our results explain how one organelle (ER) monitors the cholesterol content of another organelle (plasma membrane), thereby maintaining membrane integrity and ensuring cell survival.
- 20 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18521-18529
Open AccessLast step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
Significance: Feedback control of cholesterol metabolism is essential for cell viability and prevention of heart attacks. Cells acquire cholesterol from receptor-mediated uptake of low-density lipoprotein, which delivers cholesterol to lysosomes. To exert feedback control, cholesterol must reach the endoplasmic reticulum (ER). Here we use a CRISPR screen to show that lysosome-derived cholesterol moves first to the plasma membrane and then to the ER. The last movement requires an enzyme that produces phosphatidylserine. This demonstrates that transmembrane movement of one lipid (cholesterol) requires another lipid (phosphatidylserine). Our results explain how one organelle (ER) monitors the cholesterol content of another organelle (plasma membrane), thereby maintaining membrane integrity and ensuring cell survival.
- Open Access
- 1 December 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (10) , 3134-3146.e6
Suppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start Codon Selection
- 1 December 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (10) , 3134-3146.e6
Open AccessSuppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start Codon Selection
- 2 July 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (29) , 201801997-E6816
Conservation of mRNA quality control factor Ski7 and its diversification through changes in alternative splicing and gene duplication
Significance: The rapid degradation of mRNAs that lack a stop codon is critical to fidelity of gene expression and in yeast, it requires Ski7. Ski7 function is not fully understood and SKI7 -like genes are not apparent in other organisms. We show that in most eukaryotes Ski7 is expressed as an alternative splice isoform from the HBS1 gene. This most conserved example of alternative splicing probably arose in the common ancestor of animals, fungi, and plants. However, in six taxa alternative splicing was replaced by duplicated genes. After each duplication the SKI7 -like gene has undergone several changes that we analyzed experimentally. The results clarify how duplicated genes diversify, identify novel SKI7 -like genes, and reveal changes in nonstop mRNA decay.
- 2 July 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (29) , 201801997-E6816
Conservation of mRNA quality control factor Ski7 and its diversification through changes in alternative splicing and gene duplication
Significance: The rapid degradation of mRNAs that lack a stop codon is critical to fidelity of gene expression and in yeast, it requires Ski7. Ski7 function is not fully understood and SKI7 -like genes are not apparent in other organisms. We show that in most eukaryotes Ski7 is expressed as an alternative splice isoform from the HBS1 gene. This most conserved example of alternative splicing probably arose in the common ancestor of animals, fungi, and plants. However, in six taxa alternative splicing was replaced by duplicated genes. After each duplication the SKI7 -like gene has undergone several changes that we analyzed experimentally. The results clarify how duplicated genes diversify, identify novel SKI7 -like genes, and reveal changes in nonstop mRNA decay.
- Open Access
- 1 September 2016
- Published by Elsevier in Cell Reports
- Vol. 16 (12) , 3348-3358
The RNA Exosome Channeling and Direct Access Conformations Have Distinct In Vivo Functions
- 1 September 2016
- Published by Elsevier in Cell Reports
- Vol. 16 (12) , 3348-3358
Open AccessThe RNA Exosome Channeling and Direct Access Conformations Have Distinct In Vivo Functions